Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
PRECISESADS receives the support from the Innovative Medicines Initiative Joint Undertaking under GA n°115565, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution
Phone: +34 958 715 500
E-mail:
facebook.com/
twitter.com/
IMI
European Union
EFPIA
This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.
PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° [115565], resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
